Fluorescence in situ hybridization markers for prediction of cervical lymph node metastases

American Journal of Pathology

Volumn 175, Issue 6, 2009, Pages 2637-2645

  Wangsa, Darawalee ^a,b   Heselmeyer Haddad, Kerstin ^a   Ried, Patricia ^b   Eriksson, Elina ^b   Schäffer, Alejandro A ^c   Morrison, Larry E ^d   Luo, Juhua ^e   Auer, Gert ^b   Munck Wikland, Eva ^b   Ried, Thomas ^a   Lundqvist, Elisabeth Åvall ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d Abbott Molecular Inc   (United States)

^e BEIJING NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; CANCER STAGING; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TARGETING; GENETIC MARKER; HUMAN; HUMAN TISSUE; LAMP3 GENE; METASTASIS; PATIENT CODING; PREDICTION AND FORECASTING; PRIORITY JOURNAL; PRKAA1 GENE; PROX1 GENE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TUMOR GENE; UTERINE CERVIX BIOPSY;

EID: 73549092920     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.090289     Document Type: Article

References (40)

1. Alston RD, Geraci M, Eden TOB, Moran A, Rowan S, Birch JM: Changes in cancer incidence in teenagers and young adults (ages 13 to 24 years) in England 1979-2003. Cancer 2008, 113:2807-2815
2. Parkin DM, Louie KS, Clifford G: Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region. Vaccine 2008, 26(Suppl 12):M1-M16
3. Waggoner SE: Cervical cancer. Lancet 2003, 361:2217-2225
4. Buckley CH, Beards CS, Fox H: Pathological prognostic indicators in cervical cancer with particular reference to patients under the age of 40 years. Br J Obstet Gynaecol 1988, 95:47-56
5. Fuller AF Jr, Elliott N, Kosloff C, Hoskins WJ, Lewis JL Jr: Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix. Gynecol Oncol 1989, 33:34-39
6. Quinn MA, Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, Heintz APM, Ngan HY, Pecorelli S: Carcinoma of the cervix uteri. (Part of the FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer). Int J Gynaecol Obstet 2006, 95(Suppl 1): S43-S103
7. Heselmeyer K, Macville M, Schröck E, Blegen H, Hellström A-C, Shah K, Auer G, Ried T: Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q. Genes Chromosomes Cancer 1997, 19:233-240
8. Heselmeyer K, Schröck E, du Manoir S, Blegen H, Shah K, Steinbeck R, Auer G, Ried T: Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 1996, 93:479-484
9. Rao PH, Arias-Pulido H, Lu XY, Harris CP, Vargas H, Zhang FF, Narayan G, Schneider A, Terry MB, Murty VVVS: Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma. BMC Cancer 2004, 4:5
10. Allen DG, White DJ, Hutchins A-M, Scurry JP, Tabrizi SN, Garland SM, Armes JE: Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancer. Br J Cancer 2000, 83:1659-1663
11. Kirchhoff M, Rose H, Petersen BL, Maahr J, Gerdes T, Lundsteen C, Bryndorf T, Kryger-Baggesen N, Christensen L, Engelholm SA, Philip J: Comparative genomic hybridization reveals a recurrent pattern of chromosomal aberrations in severe dysplasia/carcinoma in situ of the cervix and in advanced-stage cervical carcinoma. Genes Chromosomes Cancer 1999, 24:144-150
12. Kanao H, Enomoto T, Kimura T, Fujita M, Nakashima R, Ueda Y, Ueno Y, Miyatake T, Yoshizaki T, Buzard GS, Tanigami A, Yoshino K, Murata Y: Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer. Cancer Res 2005, 65:8640-8645
13. Tervala T, Suominen E, Saaristo A: Targeted treatment for lymphedema and lymphatic metastasis. Ann NY Acad Sci 2008, 1131:215-224
14. Wigle JT, Oliver G: Prox1 function is required for the development of the murine lymphatic system. Cell 1999, 98:769-778
15. Witte MH, Jones K, Wilting J, Dictor M, Selg M, McHale N, Gershenwald JE, Jackson DG: Structure function relationships in the lymphatic system and implications for cancer biology. Cancer Metastasis Rev 2006, 25:159-184
16. Huang FY, Chiu PM, Tam KF, Kwok YK, Lau ET, Tang MHY, Ng TY, Liu VWS, Cheung ANY, Ngan HYS: Semi-quantitative fluorescent PCR analysis identifies PRKAA1 on chromosome 5 as a potential candidate cancer gene of cervical cancer. Gynecol Oncol 2006, 103:219-225
17. Myo K, Uzawa N, Miyamoto R, Sonoda I, Yuki Y, Amagasa T: Cyclin D1 gene numerical aberration is a predictive marker for occult cervical lymph node metastasis in TNM Stage I and II squamous cell carcinoma of the oral cavity. Cancer 2005, 104:2709-2716
18. Heselmeyer-Haddad K, Janz V, Castle PE, Chaudhri N, White N, Wilber K, Morrison LE, Auer G, Burroughs FH, Sherman ME, Ried T: Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia. Am J Pathol 2003, 163:1405-1416
19. Dursun P, Yuce K, Usubutun A, Ayhan A: Cyclooxygenase-2 expression in cervical intraepithelial neoplasia III and squamous cell cervical carcinoma, and its correlation with clinicopathologic variables. Int J Gynecol Cancer 2007, 17:164-173
20. Kodama J, Hasengaowa, Kusumoto T, Seki N, Matsuo T, Ojima Y, Nakamura K, Hongo A, Hiramatsu Y: Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer. Ann Oncol 2007, 18:70-76
21. Urabe A, Matsumoto T, Kimura M, Sonoue H, Kinoshita K: Grading system of lymphatic invasion according to D2-40 immunostaining is useful for the prediction of nodal metastasis in squamous cell carcinoma of the uterine cervix. Histopathology 2006, 49:493-497
22. Yamazaki T, Tomita S, Ichikawa K, Ono Y, Inaba F, Fukasawa I, Imai Y, Imura J, Fukui H, Fujimori T, Inaba N: P16-immunostaining pattern as a predictive marker of lymph node metastasis and recurrence in early uterine cervical cancer. Pathobiology 2006, 73:176-182
23. Mulvany NJ, Allen DG, Wilson SM: Diagnostic utility of p16INK4a: a reappraisal of its use in cervical biopsies. Pathology 2008, 40:335-344
24. Baltazar F, Filho AL, Pinheiro C, Moreira MAR, Queiroz GS, Oton GJB, Júnior AF, Ribeiro LFJ, Schmitt FC: Cyclooxygenase-2 and epidermal growth factor receptor expressions in different histological subtypes of cervical carcinomas. Int J Gynecol Pathol 2007, 26:235-241
25. Biewenga P, Buist MR, Moerland PD, Ver Loren van Themaat E, van Kampen AHC, ten Kate FJW, Baas F: Gene expression in early stage cervical cancer. Gynecol Oncol 2008, 108:520-526
26. Kim T-J, Choi J-J, Kim WY, Choi CH, Lee J-W, Bae D-S, Son D-S, Kim J, Park BK, Ahn G, Cho EY, Kim B-G: Gene expression profiling for the prediction of lymph node metastasis in patients with cervical cancer. Cancer Sci 2008, 99:31-38
27. Holmgren L, O'Reilly MS, Folkman J: Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995, 1:149-153
28. Yuan S-H, Liang X-F, Jia W-H, Huang J-L, Wei M, Deng L, Liang L-Z, Wang X-Y, Zeng Y-X: Molecular diagnosis of sentinel lymph node metastases in cervical cancer using squamous cell carcinoma antigen. Clin Cancer Res 2008, 14:5571-5578
29. Marchiolè P, Buènerd A, Scoazec J-Y, Dargent D, Mathevet P: Sentinel lymph node biopsy is not accurate in predicting lymph node status for patients with cervical carcinoma. Cancer 2004, 100:2154-2159
30. Gusterson BA: The new TNM classification and micrometastases. Breast 2003, 12:387-390
31. Heselmeyer-Haddad K, Sommerfeld K, White NM, Chaudhri N, Morrison LE, Palanisamy N, Wang ZY, Auer G, Steinberg W, Ried T: Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer. Am J Pathol 2005, 166:1229-1238
32. Huang K-F, Lee W-Y, Huang SC, Lin YS, Kang CY, Liou CP, Tzeng CC: Chromosomal gain of 3q and loss of 11q often associated with nodal metastasis in early stage cervical squamous cell carcinoma. J Formos Med Assoc 2007, 106:894-902
33. Nathanson SD: Insights into the mechanisms of lymph node metastasis. Cancer 2003, 98:413-423
34. Saharinen P, Tammela T, Karkkainen MJ, Alitalo K: Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol 2004, 25:387-395
35. Shimoda M, Takahashi M, Yoshimoto T, Kono T, Ikai I, Kubo H: A homeobox protein, prox1, is involved in the differentiation, proliferation, and prognosis in hepatocellular carcinoma. Clin Cancer Res 2006, 12:6005-6011
36. Van den Eynden GG, Van der Auwera I, Van Laere SJ, Trinh XB, Colpaert CG, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA: Comparison of molecular determinants of angiogenesis and lymphangiogenesis in lymph node metastases and in primary tumours of patients with breast cancer. J Pathol 2007, 213:56-64
37. Laerm A, Helmbold P, Goldberg M, Dammann R, Holzhausen H-J, Ballhausen WG: Prospero-related homeobox 1 (PROX1) is frequently inactivated by genomic deletions and epigenetic silencing in carcinomas of the bilary system. J Hepatol 2007, 46:89-97
38. Petrova TV, Nykanen A, Norrmén C, Ivanov KI, Andersson LC, Haglund C, Puolakkainen P, Wempe F, von Melchner H, Gradwohl G, Vanharanta S, Aaltonen LA, Saharinen J, Gentile M, Clarke A, Taipale J, Oliver G, Alitalo K: Transcription factor PROX1 induces colon cancer progression by promoting the transition from benign to highly dysplastic phenotype. Cancer Cell 2008, 13:407-419
39. Kato K, Ogura T, Kishimoto A, Minegishi Y, Nakajima N, Miyazaki M, Esumi H: Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation. Oncogene 2002, 21:6082-6090
40. Bernards R, Weinberg RA: A progression puzzle. Nature 2002, 418:823